N
Neuland Laboratories
NEULANDLAB Share Price
Healthcare13,034.00
as on 06 Mar 2026 at 15:29
Market Cap
₹16,722 Cr
PE Ratio
92.90
ROCE
20.69%
NEULANDLAB Fundamentals
Company Valuation
Market Cap (₹ Cr.)
16,722
PE Ratio
92.90
PB Ratio
10.28
Dividend Yield
0.09%
ROE
17.06%
ROCE
20.69%
Book Value (₹)
1,262.09
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 32.68% | 32.68% | 32.68% | 32.64% | 32.63% |
| Domestic Institutional Investors (DII) | 9.08% | 10.97% | 11.57% | 13.54% | 14.71% |
| Foreign Institutional Investors (FII) | 23.86% | 22.11% | 21.69% | 20.60% | 20.90% |
| Public Investors | 26.05% | 25.86% | 25.55% | 24.72% | 24.31% |
| Government | 0.40% | 0.40% | 0.40% | 0.40% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
NEULANDLAB Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Smallcap
BSE Scrip Code
524558
NSE Scrip Name
NEULANDLAB
ISIN
INE794A01010



